NO20061357L - Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelser - Google Patents
Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelserInfo
- Publication number
- NO20061357L NO20061357L NO20061357A NO20061357A NO20061357L NO 20061357 L NO20061357 L NO 20061357L NO 20061357 A NO20061357 A NO 20061357A NO 20061357 A NO20061357 A NO 20061357A NO 20061357 L NO20061357 L NO 20061357L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- chelerytrin
- disorders
- pharmaceutically acceptable
- analogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Anvendelsen av chelerytrin og chelerytrinanaloger i farmasøytiske blandinger til behandling av prefrontale kortikale kognitive forstyrrelser, inklusivt blant annet bipolar sykdom, beskrives. Foreliggende farmasøytiske blandinger omfatter en effektiv mengde av en forbindelse eller en stereoisomer, et farmasøytisk akseptabelt salt, solvat eller polymorf derav i henhold til strukturen: formel (I) eller (II), hvor: R1 og R2 uavhengig er valgt fra H, C1 -C3-alkyl, F, Cl, Br, I, OH, O(C1-C6-alkyl), O-C(=O)-(C1-C6)-alkyl eller C(=O)-O-(C1-C6)-alkyl; R3 er H eller en Cl-C6-alkylgruppe; R4 , R5 , R6 , R7 og R8 er uavhengig valgt fra H, C1-C6-alkyl, F, Cl, Br, I, OH, -(CH2)nO(C1-C6-alkyl), -(CH2)nO-C(=O)-(C1-C6)-alkyl eller -(CH2)nC(=O)-O-(C1-C6)-alkyI; R9 og R10 er uavhengig H, C1-C6-alkyl, eller danner sammen en -(CH2)m -gruppe for å gi en 5-7-leddet ring; n er fra 0 til 5; m er fra 1 til 3; og A- er et farmasøytisk akseptabelt anion av et farmasøytisk salt som danner et salt med den kvaternæriserte amingruppe, eventuelt i kombinasjon med en farmasøytisk akseptabel bærer eller hjelpestoff.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/672,626 US20050070565A1 (en) | 2003-09-26 | 2003-09-26 | Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders |
PCT/US2004/031567 WO2005030143A2 (en) | 2003-09-26 | 2004-09-27 | Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061357L true NO20061357L (no) | 2006-06-16 |
Family
ID=34376422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061357A NO20061357L (no) | 2003-09-26 | 2006-03-24 | Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelser |
Country Status (11)
Country | Link |
---|---|
US (2) | US20050070565A1 (no) |
EP (1) | EP1662875A4 (no) |
JP (1) | JP2007506784A (no) |
CN (1) | CN1859846A (no) |
AU (1) | AU2004275852A1 (no) |
BR (1) | BRPI0414816A (no) |
CA (1) | CA2540151A1 (no) |
IL (1) | IL174303A0 (no) |
MX (1) | MXPA06003423A (no) |
NO (1) | NO20061357L (no) |
WO (1) | WO2005030143A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7928070B2 (en) | 2000-04-20 | 2011-04-19 | The Research Foundation Of State University Of Ny | Memory enhancing protein |
US20080145351A1 (en) * | 2000-04-20 | 2008-06-19 | The Research Foundation Of State University Of New York | Memory influencing protein |
WO2007089774A2 (en) * | 2006-01-31 | 2007-08-09 | Yale University | Compositions and methods for treating cognitive disorders |
US8362028B2 (en) * | 2006-07-31 | 2013-01-29 | Yale University | Pseudobase benzo[c]phenanthridines with improved efficacy, stability and safety |
WO2008048194A1 (en) * | 2006-10-20 | 2008-04-24 | Yesilogluj Aysegul Yildiz | Use of the protein kinase c inhibitor tamoxifen for the treatment of bipolar disorder |
CN101209043B (zh) * | 2006-12-27 | 2011-08-10 | 长沙世唯科技有限公司 | 血根碱或白屈菜红碱在血吸虫病防治上的应用 |
WO2008118403A2 (en) * | 2007-03-22 | 2008-10-02 | Yale University | Method of using a pkc inhibitor to reverse prefrontal cortical declines |
WO2011022292A2 (en) * | 2009-08-19 | 2011-02-24 | Lunera Research, Inc. | Method of treating bipolar disorder or depression using an antiestrogen |
US20170189391A1 (en) * | 2015-12-31 | 2017-07-06 | Macau University of Science ang Technology | Protein kinase C inhibitor for treating triple-negative breast cancer |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4683133A (en) * | 1985-08-20 | 1987-07-28 | Vipont Laboratories, Inc. | Method for treating periodontal disease |
US5747502A (en) * | 1989-12-13 | 1998-05-05 | Nippon Kayaku Kabushiki Kaisha | Process for preparing benzo c!phenanthridinium derivatives, novel compounds prepared by said process, and antitumor agents |
JP2784104B2 (ja) * | 1991-08-06 | 1998-08-06 | 三菱電機株式会社 | タイミングシミュレーションシステム |
US5922571A (en) * | 1997-03-06 | 1999-07-13 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a protein kinase C homolog |
US6717030B2 (en) * | 1998-07-06 | 2004-04-06 | The Regents Of The University Of California | Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
AUPQ801700A0 (en) * | 2000-06-07 | 2000-06-29 | Peplin Research Pty Ltd | Enzyme and viral activation |
US6664266B2 (en) * | 2002-03-14 | 2003-12-16 | Children's Medical Center Corporation | Axon regeneration with PKC inhibitiors |
-
2003
- 2003-09-26 US US10/672,626 patent/US20050070565A1/en not_active Abandoned
-
2004
- 2004-09-27 BR BRPI0414816-9A patent/BRPI0414816A/pt not_active IP Right Cessation
- 2004-09-27 WO PCT/US2004/031567 patent/WO2005030143A2/en active Application Filing
- 2004-09-27 MX MXPA06003423A patent/MXPA06003423A/es unknown
- 2004-09-27 CN CNA2004800280172A patent/CN1859846A/zh active Pending
- 2004-09-27 EP EP04785084A patent/EP1662875A4/en not_active Withdrawn
- 2004-09-27 JP JP2006528278A patent/JP2007506784A/ja not_active Withdrawn
- 2004-09-27 AU AU2004275852A patent/AU2004275852A1/en not_active Abandoned
- 2004-09-27 CA CA002540151A patent/CA2540151A1/en not_active Abandoned
-
2006
- 2006-03-13 IL IL174303A patent/IL174303A0/en unknown
- 2006-03-24 NO NO20061357A patent/NO20061357L/no not_active Application Discontinuation
-
2009
- 2009-08-25 US US12/546,737 patent/US20100222376A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2540151A1 (en) | 2005-04-07 |
WO2005030143A3 (en) | 2005-09-15 |
IL174303A0 (en) | 2006-08-01 |
WO2005030143A2 (en) | 2005-04-07 |
CN1859846A (zh) | 2006-11-08 |
US20100222376A1 (en) | 2010-09-02 |
EP1662875A4 (en) | 2009-04-15 |
US20050070565A1 (en) | 2005-03-31 |
MXPA06003423A (es) | 2006-06-27 |
JP2007506784A (ja) | 2007-03-22 |
BRPI0414816A (pt) | 2006-11-14 |
AU2004275852A1 (en) | 2005-04-07 |
EP1662875A2 (en) | 2006-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20061357L (no) | Chelerytrin, analoger derav og deres anvendelse i behandling av bipolare, forstyrrelser og andre koginitive forstyrrelser | |
BRPI0308696B8 (pt) | composto derivado de quinolina, seu processo de preparação, sua composição farmacêutica e seus usos | |
AR041566A1 (es) | Derivados de indol utiles para el tratamiento de enfermedades | |
KR100878416B1 (ko) | 피페라진 화합물 | |
AR040500A1 (es) | Inhibidores de cinasas | |
FI960751A0 (fi) | Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi | |
NO963066D0 (no) | Substituerte 3-aryliden-7-azaoksindolforbindelser og fremgangsmåte for deres fremstilling | |
AR033525A1 (es) | Arilmetilaminas sustituidas, composiciones farmaceuticas, uso de las mismas para la manufactura de un medicamento | |
DK0862567T3 (da) | 5-azabicyclo[3.1.0]hexylalkyl-2-piperidoner og-glutarimider som neurokininreceptorantagonister | |
AP2001002307A0 (en) | B3 adrenergic receptor agonists and uses thereof. | |
NO20062617L (no) | Anvendelse av glukosidase inhibitorer for terapi av mucovisidose | |
YU8703A (sh) | Derivati 4-fenil-piridina kao antagonisti receptora neurokinina-1 | |
AR035479A1 (es) | Derivados de eteres biarilicos y sus sales, composiciones farmaceuticas que los comprenden y procedimientos para el tratamiento de trastornos o afecciones | |
AR057810A1 (es) | Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo y composicion farmaceutica | |
HRP20020175B1 (en) | N-heterocyclikc derivatives as nos inhibitors | |
MX2009003802A (es) | Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta-2 adrenergico. | |
BRPI0519287A2 (pt) | derivados de amida | |
AR041055A1 (es) | Derivados de benzoimidazol utiles como agentes antiproliferativos, composicion farmaceautica en base al compuesto y un procedimiento de preparacion del compuesto | |
HUP0402225A2 (hu) | Makrolid-vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
HUP0101281A2 (hu) | Glicin transzport inhibitor hatású difenil-piperidin-butánamid-származékok, eljárás előállításukra, alkalmazásuk gyógyszerkészítmények előállítására és a vegyületeket tartalmazó gyógyszerkészítmények | |
RS49684B (sr) | Upotreba derivata 7-(2-oksa-5,8- diazabiciklo[4.3.0]non-8-il)-hinolon- karbonske kiseline i nafthiridonkarbonske kiseline za pripremanje leka za terapiju helikobakter-pilori infekcija i sa time povezanim gastroduodenalnim oboljenjima | |
PE20090620A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
NO20063597L (no) | Acetylinske piperazinforbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
AR040489A1 (es) | Compuestos derivados de 3-fenil-propionamido, 3-fenil-acrilamido y 3-fenil-propinamido, su uso para la elaboracion de medicamentos, un proceso para elaborar los compuestos y medicamentos que los contienen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |